Hansen Medical, Inc., a global leader in intravascular robotics, today announced that it will exhibit its Magellan™ Robotic System at the Vascular InterVentional Advances (VIVA) conference, from October 8-11 at the Wynn Hotel in Las Vegas. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 212.
"We are excited for the opportunity to further showcase our technology at this important annual meeting of leading clinicians focused on the peripheral vasculature," said Bruce Barclay, President and CEO of Hansen Medical. "Based on the feedback from many successful cases at leading centers across the U.S. and Europe, the precision and control offered by the Magellan Robotic System are helping to bring predictability to a broad variety of endovascular procedures, including endovascular aneurysm repair (EVAR), carotid stenting, peripheral embolization, and chronic total occlusions. In addition, the Magellan System has the potential to allow hospitals and health systems to improve the efficiency and utilization of their most profitable assets -- their operating rooms and cath labs -- by reducing procedure times and streamlining endovascular procedures. With several new robotic catheters in development, we believe the Magellan Robotic System has an important role to play in driving the continued evolution of endovascular treatment options for patients with peripheral vascular disease."
About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is intended to be used to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. Magellan is designed to deliver predictability to simple and complex endovascular procedures. Since its commercial introduction in the US and Europe, the Magellan System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedure types in centers across the US and Europe. The system is based upon the flexible robotic technology incorporated in the Sensei-X® Robotic Catheter System currently sold in the U.S. and Europe, which has been used in more than 10,000 patients, but includes a number of key enhancements. In particular, the Magellan Robotic System:
- Provides solid catheter stability for placement of therapeutic devices.
- Is designed to enable predictable procedure times and increased case throughput.
- Allows for independent, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires.
- Is designed to allow for sufficient extension inside the body to access hard to reach peripheral anatomy.
- Preserves the open architecture featured in the Sensei System to allow for the subsequent use of many 6F therapeutic devices on the market today.
- Is designed to potentially reduce physician radiation exposure and fatigue by employing a remote physician workstation.